GLP3 RT 20

GLP3RT 

HPLC: 99.56%

A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors—currently in advanced clinical trials for obesity and metabolic disorders. It’s being studied for its potent effects on appetite regulation, insulin sensitivity, and lipid metabolism.

Disclaimer

All research peptides sold by Sydney bio labs undergo independent third-party testing to verify composition and purity prior to sale and are provided for research and laboratory use only.

• FOR RESEARCH USE ONLY (RUO)
• NOT FOR HUMAN CONSUMPTION
• NOT FOR HUMAN OR VETERINARY USE
• Not intended to diagnose, treat, cure, or prevent any disease.
• Not intended for injection or other administration.
• Handle and store according to applicable laboratory procedures.
• Keep out of reach of children and unauthorized persons.
• Use only by appropriately trained personnel in a suitable research environment.